RNA sequencing, bioinformatics analysis, detection of FAO and glucose oxidation, co‐immunoprecipitation, and drug screening were used to explore the molecular mechanisms underlying the role of Decr1 in DCM pathogenesis. The gene discussed is DECR1; the disease is familial dilated cardiomyopathy.